Trazodone is an antidepressant medicine that works to balance chemicals in the brain. It’s used to treat depression, anxiety, or a combination of depression and anxiety. It can help if you’re having problems like low mood, poor sleep and poor concentration. Trazodone comes as tablets, capsules and liquid. Global Trazodone Hydrochloride (API) Market was valued at just under USD 345 million in 2019 and is expected to reach over USD 615 million in 2027, growing at a CAGR of over 7.5% during the forecast period.
By type, global Trazodone Hydrochloride (API) market is segmented into Capsule and Tablet. In 2019, global Trazodone Hydrochloride (API) market was dominated by tablet segment with over 50% share in total revenue generation. It is also expected to be one of the fastest growing segments over the forecast period and maintain its dominance.
Download FREE Sample PDF of Global Trazodone Hydrochloride (API) Market: https://www.eonmarketresearch.com/sample/76630
Global Trazodone Hydrochloride (API) market is segmented on the basis of applications such as Antidepression, Anxiolytic, Hypnotic and Others. Antidepression segment dominated the global Trazodone Hydrochloride market with over 32.5% share in 2019. Like most antidepressants, trazodone has additionally been utilized in restricted quantities of patients to treat alarm issue, over the top habitual problem, consideration deficiency/hyperactivity issue, enuresis (bed-wetting), dietary issues, for example, bulimia nervosa, cocaine reliance, and the burdensome period of bipolar (hyper burdensome) jumble. It should be noted, notwithstanding, that trazodone has not gotten official endorsement from the United States Food and Drug Administration (FDA) for these optional employments.
North America dominated the global Trazodone Hydrochloride (API) market in 2019 with over 80% share in total revenue generated by this industry. North America is closely followed by the Europe.
Major players in global Trazodone Hydrochloride (API) market include but not limited to Teva, Angelini, Mylan, Fermion, The Piramal Group and others. The global Trazodone Hydrochloride (API) market is highly concentrated with top six players accounting for just over 45% share in the global market.
Buy This Premium Report: https://www.eonmarketresearch.com/buy/76630
Trazodone Hydrochloride (API) Market by Type, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
Trazodone Hydrochloride (API) Market by Application, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
Trazodone Hydrochloride (API) Market by Region, 2015 – 2027 Volume (Tons) and Revenue (USD Million)
- United States
- South Korea
- Southeast Asia
Middle East and Africa
- Saudi Arabia
- South Africa
Trazodone Hydrochloride (API) Market by Company, 2018 – 2019 Volume (Tons) and Revenue (USD Million)
- The Piramal Group
Do Inquiry Before Purchasing Report Here and Ask For Discount: https://www.eonmarketresearch.com/enquiry/76630
Explore Related Reports:
- Ganciclovir Market
- Kifunensine Market
- Solid Organ Transplant Immunosuppressant Market
- Primary Hyperoxaluria Drug Market
- Cerebroprotein Hydrolysate Market
- Caries Detection Devices Market
Eon Market Research (EMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers.
Eon Market Research
Phone: +1 703 879 7090